P659-2030 Screening compound: 1-butyl-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine

P659-2030 Screening compound: 1-butyl-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine
P659-2030 Screening compound: 1-butyl-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound P659-2030
1-butyl-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P659-2030

Molecular Formula

C21H35N7 (C21 H35 N7)

Compound Name

1-butyl-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine

IUPAC name

1-butyl-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[124]triazolo[15-a]pyrimidin-2-yl]methyl}piperazine

SMILES

CCCCN1CCN(Cc2nn3c(N4CCC(C)CC4)cc(C)nc3n2)CC1

InChI

InChI=1S/C21H35N7/c1-4-5-8-25-11-13-26(14-12-25)16-19-23-21-22-18(3)15-20(28(21)24-19)27-9-6-17(2)7-10-27/h15,17H,4-14,16H2,1-3H3

InChI Key

DGEQQYJVGWCGPF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27609861

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

385.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.926

Distribution Coefficient, logD

1.841

Water Solubility, LogSw

-2.89

Polar Surface Area

41.902

Acid Dissociation Constant (pKa)

24.11

Base Dissociation Constant (pKb)

8.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

76.20

P659-2030 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with P659-2030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P659-2030?
Check Price and Availability of P659-2030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P659-2030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P659-2030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P659-2030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P659-2030 available by request